Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Zoster Vaccine (SHINGRIX) Phase IV Trial in Chinese Adults ≥50 Years
CTR20201272Phase 4Completed
- Sponsor
- ---
- Start
- Mar 2021
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Zoster vaccine recombinant in herpes zoster (HZ), sponsored by ---. Started Mar 2021; status: completed.
02
Drugs
Zoster vaccine recombinant
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on CTR20201272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201272.